Iterum Therapeutics upsizes ATM offering by up to $25M, previously raised $16M

Iterum Therapeutics plc

Filed prospectus supplement on Dec 10, 2024 for additional gross proceeds up to $25M.
Prior sales under same ATM agreement totaled approx $16M gross proceeds.
Sales agent is H.C. Wainwright & Co., LLC under agreement dated Oct 7, 2022.
Shares offered via S-3 registration statement; legal opinion from A&L Goodbody LLP attached.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.